Alteration in ATR protein level does not account for the inherent radiosensitivity of HPV-positive head and neck squamous cell carcinoma

被引:0
|
作者
Kohl, Sibylla [1 ]
Subtil, Florentine S. B. [1 ]
Climenti, Vanessa [1 ]
Anees, Houmam [1 ]
Parplys, Ann C. [1 ]
Engenhart-Cabillic, Rita [1 ,2 ]
Adeberg, Sebastian [1 ,2 ]
Dikomey, Ekkehard [1 ,3 ]
Theiss, Ulrike [1 ,2 ]
机构
[1] Philipps Univ Marburg, Dept Radiotherapy & Radiat Oncol, Marburg, Germany
[2] Marburg Univ Hosp, Marburg Ion Beam Therapy Ctr MIT, Dept Radiotherapy & Radiat Oncol, Marburg, Germany
[3] Univ Med Ctr Hamburg Eppendorf, Lab Radiobiol & Expt Radiooncol, Hamburg, Germany
来源
TRANSLATIONAL ONCOLOGY | 2025年 / 55卷
关键词
Head and neck squamous cell carcinoma; Human papilloma virus; ATR; Radiosensitivity; DSB repair; HR; MEDIATED RADIOSENSITIZATION; CANCER; INHIBITION; LINES; OLAPARIB; AZD6738;
D O I
10.1016/j.tranon.2025.102359
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: Human papilloma virus (HPV)-positive head and neck squamous cell carcinoma (HNSCC) cells are highly radiosensitive resulting from an elevated number of DNA double-strand breaks (DSB) remaining after irradiation. Partially this effect is due to a defective homologous recombination (HR). HPV-positive cells also show pronounced instability of chromosome 3, which codes for the kinase ataxia-telangiectasia and Rad3-related (ATR) protein, a central player of HR. If there is a contribution of ATR to the radiosensitivity of HPV-positive cells remains unclear, and this in-vitro study tested a functional involvement of ATR expression. Methods: The study was performed with six HPV-negative and six HPV-positive HNSCC cell lines. Gene copy number and gene expression were determined via qRT-PCR, protein expression by Western Blot. Response of cells towards irradiation in dependence of ATR expression was tested after siRNA Knock-down (ATRKD). Clonogenic survival after photon irradiation was evaluated by colony formation assay and DSBs were visualized by gamma H2AX/53BP1 co-staining. Results: ATR gene copy number and expression were not altered. Protein level was almost two-fold lower in HPVpositive compared to HPV-negative cells, but fully functional as observed by active phosphorylation in response towards irradiation. ATRKD resulted in a further increase in both, radiosensitivity as well as number of residual DSBs, but only for HPV-positive cells. Conclusion: Since the effect of ATRKD was compensated in HPV-negative but not in HPV-positive cells, these data revealed that the two-fold lower level of ATR in HPV-positive cells does not account for their enhanced inherent radiosensitivity, but acts additive to irradiation.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Locoregional Recurrence of an HPV-Positive Squamous Cell Carcinoma of the Head and Neck
    Bowles, Daniel W.
    Reddy, Krishna
    Wine, Todd
    Ree, Alexander
    Raben, David
    Chen, Changhu
    Jimeno, Antonio
    ONCOLOGY-NEW YORK, 2011, 25 (11): : 1042 - 1048
  • [2] The radiobiology of HPV-positive and HPV-negative head and neck squamous cell carcinoma
    Zhou, Chumin
    Parsons, Jason L.
    EXPERT REVIEWS IN MOLECULAR MEDICINE, 2020, 22
  • [3] β-CATENIN is a positive prognostic marker for HPV-positive head and neck squamous cell carcinoma
    Stefan Stoiber
    Faris F. Brkic
    Tobias Maier
    Julia Schnoell
    Elisabeth Gurnhofer
    Gregor Heiduschka
    Lorenz Kadletz-Wanke
    Lukas Kenner
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 7743 - 7750
  • [4] β-CATENIN is a positive prognostic marker for HPV-positive head and neck squamous cell carcinoma
    Stoiber, Stefan
    Brkic, Faris F.
    Maier, Tobias
    Schnoell, Julia
    Gurnhofer, Elisabeth
    Heiduschka, Gregor
    Kadletz-Wanke, Lorenz
    Kenner, Lukas
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (10) : 7743 - 7750
  • [5] Misregulation of DNA damage repair pathways in HPV-positive head and neck squamous cell carcinoma contributes to cellular radiosensitivity
    Nickson, Catherine M.
    Moori, Parisa
    Carter, Rachel J.
    Rubbi, Carlos P.
    Parsons, Jason L.
    ONCOTARGET, 2017, 8 (18) : 29963 - 29975
  • [6] Elucidation of treatment resistance factors in HPV-positive squamous cell carcinoma of the head and neck
    Saeda, Kenta
    Okabe, Atsushi
    Kita, Kazuko
    Hoshii, Takayuki
    Fukuyo, Masaki
    Kurokawa, Tomoya
    Nakagawa, Takuya
    Bahityar, Rahmutulla
    Hanazawa, Toyoyuki
    Kaneda, Atsushi
    CANCER SCIENCE, 2025, 116 : 1133 - 1133
  • [7] Patterns of distant metastases in HPV-positive head and neck squamous cell carcinoma.
    Law, Jennie York
    Chen, Susie Anne
    Gerber, David E.
    Hughes, Randall S.
    Madrigales, Alejandra
    Myers, Larry L.
    Nedzi, Lucien Alexander
    Sumer, Baran D.
    Truelson, John
    Yordy, John Stuart
    Zhu, Hong
    Khan, Saad A.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [8] Development and Characterization of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinoma Tumorgrafts
    Kimple, Randall J.
    Harari, Paul M.
    Torres, Alexandra D.
    Yang, Robert Z.
    Soriano, Benjamin J.
    Yu, Menggang
    Armstrong, Eric A.
    Blitzer, Grace C.
    Smith, Molly A.
    Lorenz, Laurel D.
    Lee, Denis
    Yang, David T.
    McCulloch, Timothy M.
    Hartig, Gregory K.
    Lambert, Paul F.
    CLINICAL CANCER RESEARCH, 2013, 19 (04) : 855 - 864
  • [9] Treatment response of HPV-positive and HPV-negative head and neck squamous cell carcinoma cell lines
    Nagel, Remco
    Martens-de Kemp, Sanne R.
    Buijze, Marijke
    Jacobs, Gerbren
    Braakhuis, Boudewijn J. M.
    Brakenhoff, Ruud H.
    ORAL ONCOLOGY, 2013, 49 (06) : 560 - 566
  • [10] Current landscape of clinical trials for HPV-positive head and neck squamous cell carcinoma (HNSCC)
    Bteich, Yara T.
    Hosri, Jad E.
    Wehbi, Jad A.
    Daou, Lea R.
    ECANCERMEDICALSCIENCE, 2022, 16